Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when designing or auditing figures for an Advanced Materials manuscript, including the lead figure, multi-panel characterization figures, and the Table-of-Contents graphic, where visual quality is a house expectation. Designs figure strategy; does not run the analysis or write prose.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
설치 방법 보기설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.
Advanced Materials is a visually demanding journal — striking, cover-quality figures are a house expectation, and the journal actively selects work for cover art. But visual polish must serve the science. The hierarchy:
If a panel does not advance the central claim or one essential link, move it to the SI.
Materials figures are dense by nature; discipline keeps them readable:
| Principle | Practice |
|---|---|
| One figure, one link | Group panels that jointly prove one claim (e.g. all structure) |
| Reading order | Label (a),(b),(c) top-left to bottom-right; caption follows it |
| Scale bars, always | Every micrograph carries a scale bar in the image, not only the caption |
| Consistent color-coding | The same sample/condition keeps one color across all figures |
| Annotate the feature | Arrow/label the lattice fringe, peak, or interface that matters |
| Overlay, don't scatter | Show theory-vs-experiment or before-vs-after on shared axes |
【Figure count】N — each essential? yes / cut list
【Fig. 1 conveys the advance at a glance】yes / redesign
【Per-figure single chain-link】list
【Scale bars on all micrographs】yes / fix
【Consistent color-coding】yes / fix
【Color-blind / grayscale safe】yes / fix
【TOC graphic】designed + blurb? yes / fix
【Next】advmat-supplementary (SI) or advmat-length-management (fit format)
Figure DPI, format, TOC-graphic, and cover-art specifications are set by Wiley and change — verify current requirements on the official Advanced Materials author page.
아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.
로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.
아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.